IDEXX Laboratories (Germany) Performance

IX1 Stock  EUR 527.20  1.80  0.34%   
The company retains a Market Volatility (i.e., Beta) of 0.34, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, IDEXX Laboratories' returns are expected to increase less than the market. However, during the bear market, the loss of holding IDEXX Laboratories is expected to be smaller as well. At this point, IDEXX Laboratories has a negative expected return of -0.22%. Please make sure to check out IDEXX Laboratories' variance, jensen alpha, and the relationship between the standard deviation and information ratio , to decide if IDEXX Laboratories performance from the past will be repeated in the future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days IDEXX Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Last Split Factor
2:1
Last Split Date
2015-06-16
1
Why IDEXX Laboratories Inc. stock stays undervalued - July 2025 Pullbacks AI Forecasted Entry and Exit Points - Newser
12/04/2025
2
Is IDEXX Laboratories Inc. stock undervalued historically - July 2025 Rallies Expert Approved Trade Ideas - ulpravda.ru
01/08/2026
3
IDEXX Labs stock steady as Stifel notes CEO transition plan - Investing.com
01/13/2026
4
Coalescence Partners Investment Management LP Sells 19,147 Shares of IDEXX Laboratories, Inc. IDXX - MarketBeat
01/21/2026
5
Nicola Wealth Management LTD. Sells 16,000 Shares of IDEXX Laboratories, Inc. IDXX - MarketBeat
01/27/2026
6
IDEXX Laboratories, Inc.s Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason - Yahoo Finance
01/30/2026
7
Alta Capital Management LLC Cuts Stock Holdings in IDEXX Laboratories, Inc. IDXX - MarketBeat
02/04/2026
8
IDEXX Laboratories, Inc. IDXX Stock Position Decreased by RFG Advisory LLC - MarketBeat
02/11/2026
  

IDEXX Laboratories Relative Risk vs. Return Landscape

If you would invest  60,740  in IDEXX Laboratories on November 20, 2025 and sell it today you would lose (8,020) from holding IDEXX Laboratories or give up 13.2% of portfolio value over 90 days. IDEXX Laboratories is currently producing negative expected returns and takes up 1.9548% volatility of returns over 90 trading days. Put another way, 17% of traded stocks are less volatile than IDEXX, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon IDEXX Laboratories is expected to under-perform the market. In addition to that, the company is 2.6 times more volatile than its market benchmark. It trades about -0.11 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.19 per unit of volatility.

IDEXX Laboratories Target Price Odds to finish over Current Price

The tendency of IDEXX Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 527.20 90 days 527.20 
about 97.0
Based on a normal probability distribution, the odds of IDEXX Laboratories to move above the current price in 90 days from now is about 97.0 (This IDEXX Laboratories probability density function shows the probability of IDEXX Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon IDEXX Laboratories has a beta of 0.34. This usually indicates as returns on the market go up, IDEXX Laboratories average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding IDEXX Laboratories will be expected to be much smaller as well. Additionally IDEXX Laboratories has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   IDEXX Laboratories Price Density   
       Price  

Predictive Modules for IDEXX Laboratories

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as IDEXX Laboratories. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
522.97524.93581.90
Details
Intrinsic
Valuation
LowRealHigh
458.27460.23581.90
Details
Earnings
Estimates (0)
LowProjected EPSHigh
1.661.902.07
Details

IDEXX Laboratories Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. IDEXX Laboratories is not an exception. The market had few large corrections towards the IDEXX Laboratories' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold IDEXX Laboratories, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of IDEXX Laboratories within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.22
β
Beta against Dow Jones0.34
σ
Overall volatility
33.15
Ir
Information ratio -0.12

IDEXX Laboratories Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of IDEXX Laboratories for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for IDEXX Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
IDEXX Laboratories generated a negative expected return over the last 90 days
Over 99.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: IDEXX Laboratories, Inc. IDXX Stock Position Decreased by RFG Advisory LLC - MarketBeat

IDEXX Laboratories Fundamentals Growth

IDEXX Stock prices reflect investors' perceptions of the future prospects and financial health of IDEXX Laboratories, and IDEXX Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IDEXX Stock performance.

About IDEXX Laboratories Performance

By analyzing IDEXX Laboratories' fundamental ratios, stakeholders can gain valuable insights into IDEXX Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if IDEXX Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if IDEXX Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine. IDEXX Laboratories operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 8000 people.

Things to note about IDEXX Laboratories performance evaluation

Checking the ongoing alerts about IDEXX Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for IDEXX Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
IDEXX Laboratories generated a negative expected return over the last 90 days
Over 99.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: IDEXX Laboratories, Inc. IDXX Stock Position Decreased by RFG Advisory LLC - MarketBeat
Evaluating IDEXX Laboratories' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate IDEXX Laboratories' stock performance include:
  • Analyzing IDEXX Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IDEXX Laboratories' stock is overvalued or undervalued compared to its peers.
  • Examining IDEXX Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating IDEXX Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of IDEXX Laboratories' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of IDEXX Laboratories' stock. These opinions can provide insight into IDEXX Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating IDEXX Laboratories' stock performance is not an exact science, and many factors can impact IDEXX Laboratories' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for IDEXX Stock analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope